Trastuzumab Charge Variants: a Study on Physicochemical and Pharmacokinetic Properties

被引:0
作者
Torkashvand, Fatemeh [1 ]
Mehranfar, Mahsa [1 ]
Gero, Mahsa Rashidi [1 ,2 ]
Jafarian, Parisa [1 ,3 ]
Mirabzadeh, Esmat [1 ]
Azarian, Bahareh [1 ]
Sardari, Soroush [1 ]
Vaziri, Behrouz [1 ,4 ]
机构
[1] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran
[2] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran
[3] Islamic Azad Univ, Fac Biol Sci, Dept Biochem, North Tehra branch, Tehran, Iran
[4] Pasteur Inst Iran, Biotechnol Res Ctr, 69,Pasteur St, Tehran 1316943551, Iran
关键词
Monoclonal antibodies; Pharmacokinetics; Trastuzumab;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Post-translational modifications in bioprocessing and storage of recombinant mAbs are the main sources of charge variants. While the profile of these kinds of variants is considered an important quality attribute of therapeutic mAbs, there is controversy about their direct role on safety and efficacy. In this study, the physicochemical and PK properties of separated charge variants belonging to a trastuzumab potential biosimilar were examined.Methods: The APs, BPs, and main variants of trastuzumab were separated and enriched by semi-preparative WCX. A panel of analytical techniques was utilized to characterize the physicochemical properties of these variants. The binding affinity to HER2 and Fc & gamma;Rs and the PK parameters were evaluated for each variant.Results: Based on the results, the charge variants of the proposed biosimilar had no significant influence on the examined efficacy and PK parameters.Conclusion: During the development and production of biosimilar mAbs, studying the effects of their charge variants on efficacy and PK parameters is needed. DOI: 10.52547/ibj.3837
引用
收藏
页码:108 / 116
页数:9
相关论文
共 50 条
  • [21] Bioprocess Challenges in Purification of Therapeutic Protein Charge Variants
    Gupta, Tarun
    Kumar, Anuj
    Seshadri, Sriram
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2023, 28 (04) : 493 - 506
  • [22] Changes of net charge and α-helical content affect the pharmacokinetic properties of human serum albumin
    Iwao, Yasunori
    Hiraike, Mikako
    Kragh-Hansen, Ulrich
    Mera, Katsumi
    Noguchi, Taishi
    Anraku, Makoto
    Kawai, Keiichi
    Maruyama, Toru
    Otagiri, Masaki
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2007, 1774 (12): : 1582 - 1590
  • [23] Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion
    Le Guyader, Guillaume
    Vieillard, Victoire
    Paul, Muriel
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (04) : 847 - 856
  • [24] A randomized, single-blind, single-dose, parallel-group study in healthy subjects to demonstrate the pharmacokinetic equivalence of trastuzumab and its biosimilar
    Wang, Yanli
    Liu, Zhengzhi
    Deng, Qiaohuan
    Su, Zhengjie
    Xue, Jinling
    Zhao, Yicheng
    Yang, Haimiao
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (11) : 849 - 855
  • [25] A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects
    Vladimir Hanes
    Vincent Chow
    Nan Zhang
    Richard Markus
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 881 - 888
  • [26] A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects
    Hanes, Vladimir
    Chow, Vincent
    Zhang, Nan
    Markus, Richard
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (05) : 881 - 888
  • [27] Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan
    Tokudome, Nahomi
    Ito, Yoshinori
    Hatake, Kiyohiko
    Toi, Masakazu
    Sano, Muneaki
    Iwata, Hiroji
    Sato, Yasuyuki
    Saeki, Toshiaki
    Aogi, Kenjiro
    Takashima, Shigemitsu
    ANTI-CANCER DRUGS, 2008, 19 (07) : 753 - 759
  • [28] Revealing charge heterogeneity of stressed trastuzumab at the subunit level
    Baubek Spanov
    Bas Baartmans
    Oladapo Olaleye
    Simone Nicolardi
    Natalia Govorukhina
    Manfred Wuhrer
    Nico C. van de Merbel
    Rainer Bischoff
    Analytical and Bioanalytical Chemistry, 2023, 415 : 1505 - 1513
  • [29] Revealing charge heterogeneity of stressed trastuzumab at the subunit level
    Spanov, Baubek
    Baartmans, Bas
    Olaleye, Oladapo
    Nicolardi, Simone
    Govorukhina, Natalia
    Wuhrer, Manfred
    van de Merbel, Nico C.
    Bischoff, Rainer
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2023, 415 (08) : 1505 - 1513
  • [30] The Physicochemical and Pharmacokinetic Relationships of Barbiturates - From the Past to the Future
    Ernst, Britton J.
    Clark, Gerald F.
    Grundmann, Oliver
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (25) : 3681 - 3691